Sanofi
Sanofi ‘considering’ raising Genzyme offer
January 19, 2011Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, pharma mergers and acquisitions
Sanofi-Aventis could be willing to raise its offer to $76 a share to buy the US biotech firm Genzyme, according …
Sanofi’s Genzyme takeover bid focuses on Campath
January 10, 2011Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, biotech acquisition
Sanofi-Aventis and Genzyme have come back to the negotiation table to discuss the potential of Genzyme’s multiple sclerosis drug Campath. …
Sanofi workers strike in France
January 7, 2011Research and Development, Sales and Marketing Sanofi, Sanofi-Aventis, strikes, unions
Sanofi-Aventis workers have gone on strike in France as the company looks to cut jobs. Nine unions representing workers at …
Sanofi signs new oncology research deals
December 20, 2010Research and Development Avila Therapeutics, Cancer, INDOX, India, Oxford University, Sanofi, Sanofi-Aventis, cancer research, covalent drugs
Sanofi-Aventis has signed two new cancer research deals, including one that will see it partner with Avila Therapeutics to discover …
Sanofi and Merck Serono to collaborate in oncology
December 17, 2010Research and Development Cancer, MSC1936369B, Merck Serono, SAR245408, SAR245409, Sanofi, Sanofi-Aventis
Sanofi-Aventis and Merck Serono are to join forces to study three new cancer drug candidates. The collaboration will see the companies …
Sanofi extends Genzyme share deal deadline
December 14, 2010Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, mergers and acquisitions, pharma acquisitions
Sanofi-Aventis has extended the deadline to acquire Genzyme after the US biotech’s shareholders have so far proved immune to its …
Genzyme courting ‘white knight’ bid from Takeda
November 18, 2010Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, Takeda, pharma mergers
Genzyme is in talks with Takeda to secure a ‘white knight’ bid that would prevent Sanofi-Aventis from taking over the …
Sanofi’s C diff vaccine fast tracked by FDA
November 10, 2010Research and Development C diff, C diff vaccine, C difficile, Clostridium difficile, FDA, FDA fast-track, Sanofi, Sanofi Pasteur
A new vaccine aimed at preventing C difficile infections has been fast tracked by the FDA. The regulator’s decision signals …
Genzyme again snubs suitor Sanofi
November 10, 2010Research and Development, Sales and Marketing Campath, Chris Viehbacher, Genzyme, Henri Termeer, Orphan Drugs, Plavix, Sanofi, Sanofi-Aventis, manufacturing compliance
Genzyme has once again snubbed Sanofi-Aventis as the French pharma firm continues its pursuit of the beleaguered biotech company. Henri …
Sanofi moves teriflunomide into phase III MS trials
October 26, 2010Research and Development MS, Sanofi, Sanofi-Aventis, TERACLES, multiple sclerosis, relapsing multiple sclerosis, teriflunomide
Sanofi-Aventis is to begin the first phase III study of an oral drug as an add-on to standard therapy in …
Staff blockade Sanofi-Aventis facility in France
October 21, 2010Manufacturing and Production France, Sanofi, Sanofi-Aventis, job cuts, manufacturing and production
Workers at a Sanofi-Aventis manufacturing facility in Romainville, France, sealed off the gates of the plant to protest plans to …
Termeer exit could help Sanofi
September 30, 2010Sales and Marketing Genzyme, M&A, MA, Sanofi
Genzyme’s chief executive Henri Termeer has signalled he will retire next year, a move which would help smooth the way …
Sanofi acquires US biotech TargeGen
June 30, 2010Research and Development Sanofi, TargeGen, haematology
Sanofi-Aventis is to buy TargeGen, a US biopharmaceutical company which develops small molecule kinase inhibitors. The drugs are used to …
Digital Pharma: First pharma iPad apps
June 25, 2010Medical Communications, Sales and Marketing Apple, Pfizer, Sanofi, app, ipad, iphone
The first big pharma apps specially designed for Apple’s iPad have started to emerge, with Pfizer and Sanofi leading the …
Sanofi signs deal on pre-clinical cancer drugs
June 4, 2010Research and Development Cancer, Sanofi
Sanofi-Aventis has signed a deal with US biotech company Ascenta to co-develop new oncology treatments aimed at restoring ‘apoptosis’ or …
Latest content
Five Facts about cardiovascular disease
